Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acquisition
Biotech
Novo CEO tells Pfizer to 'bid higher' if it wants to win Metsera
Amid the whiplash bidding war for obesity biotech Metsera, Novo Nordisk's CEO has, quite literally, told Pfizer to put its money where its mouth is.
Fraiser Kansteiner
Nov 7, 2025 10:00am
Publisher’s note: Questex acquires The Conference Forum, Versalinx
Nov 4, 2025 12:00pm
Cardiometabolic field drives M&A while cancer deals drop: report
Oct 27, 2025 2:39pm
Ipsen inks €1B buyout of French biotech ImCheck
Oct 22, 2025 10:33am
Concentra strikes again, circling up IGM Biosciences
Jul 1, 2025 9:58am
Lilly lands next-gen pain asset in $1B SiteOne acquisition
May 27, 2025 11:30am
